Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2018/09/015683
CTRI/2018/09/015683
Recruiting
Phase 3

Clinical Evaluation Of Ayurveda- Based Integrative Management Of Diabetic Retinopathy - DRAIM

Dr GG Gangadharan0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: H350- Background retinopathy and retinalvascular changesHealth Condition 2: H352- Other non-diabetic proliferative retinopathy

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: H350- Background retinopathy and retinalvascular changesHealth Condition 2: H352- Other non-diabetic proliferative retinopathy
Sponsor
Dr GG Gangadharan
Status
Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr GG Gangadharan

Eligibility Criteria

Inclusion Criteria

  • •Non insulin dependent diabetes mellitus
  • •\-Mild to Moderate Diabetic Retinopathy

Exclusion Criteria

  • •\-Patients with H/O Previous treatment for diabetic retinopathy, including laser and Anti\- VEGF drug.
  • •\-Presence of severe non\-proliferative diabetic retinopathy or proliferative diabetic retinopathy
  • •\-Other ophthalmic conditions such as Cataract etc.
  • •\-Presence of diabetic nephropathy or cardiovascular disease
  • •\-Pregnancy or Lactation
  • •\-HbA1C \>10%
  • •\-Statin Use

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Efficacy of Aswagandha and Mandookaparni in Manodwega (GAD) patients
CTRI/2017/07/009095Central council for Research in Ayurvedic sciences100
Not yet recruiting
Not Applicable
Evaluation of Role of Ayurvedic Drug- Guduchi Ghan Vati in the treatment of COVID-19 related illness
CTRI/2020/05/025370Dr SR Rajasthan Ayurved University Jodhpur
Completed
Phase 3
Effect of Ayurveda intervention AYUSH-64 add-on therapy for patients with COVID-19 infection (Stage I)Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
CTRI/2020/05/025156Central Council for Research in Ayurvedic Sciences60
Completed
Phase 2
Evaluation of Efficacy and Safety of Ayurveda Intervention (Ayush -64) in the management of COVID-19 infection (Asymptomatic &Mild to Moderate symptoms
CTRI/2020/05/025338Central Council For Research in Ayurvedic Sciences40
Not yet recruiting
Phase 2
Study of use of Ayurveda Intervention (Ayush-64) in COVID 19
CTRI/2020/06/026002ational Institute of Ayurveda